← Leaderboards
Ramin Mojtabai
Columbia University Health Sciences
$6,976,623
Attributed
$9,320,173
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,320,173 · 10
By mechanism
R01$8,445,253 · 8
K01$664,583 · 1
R34$210,337 · 1
Top collaborators
- Rosa M Crum6 shared
- Mark Olfson5 shared
- Helaine Rutkow2 shared
- Lawrence S. Wissow1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Frances Rudnick Levin$39,078,718
- Pamela U Freda$13,039,453
- Jonathan A Javitch$40,288,430
- Angel V Peterchev$13,708,301
- Judith Korner$12,592,020
Others in their field
Top investigators on “Services”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,236,423,805
- Leonard Freedman · Leidos Biomedical Research, Inc.$868,224,440
- Larry Arthur$689,089,782
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
ServicesFollow-UpSurveysParticipantDrug UsageVariantSubstance Use DisorderSubgroupFutureTreatment OutcomeCharacteristicsNational Institute Of Drug AbusePoliciesTreatment EffectSamplingCommunitiesComorbiditySocialAmericanDesignAlcoholsPatternCaringAdult
Grant awards (31)
Substance Use Treatment Outcomes: Effect of Psychiatric Comorbidity$360,250
R01 · FY2025 · DA
Short-term Outcome of Stimulant Use Disorder Treatment Trials$403,206
R01 · FY2024 · DA · contact PI
Substance Use Treatment Outcomes: Effect of Psychiatric Comorbidity$360,250
R01 · FY2024 · DA
Short-term Outcome of Stimulant Use Disorder Treatment Trials$409,375
R01 · FY2023 · DA · contact PI
Substance Use Treatment Outcomes: Effect of Psychiatric Comorbidity$360,250
R01 · FY2023 · DA · contact PI
Short-term Outcome of Stimulant Use Disorder Treatment Trials$409,375
R01 · FY2022 · DA · contact PI
Health Care Policy and Substance Abuse Treatment Access$381,830
R01 · FY2022 · DA
Health Care Policy and Substance Abuse Treatment Access$380,180
R01 · FY2020 · DA
Clean Indoor Air Laws, Cigarette Taxes, and Use of Smoking Cessation Treatments$368,438
R01 · FY2020 · DA · contact PI
Health Care Policy and Substance Abuse Treatment Access$380,180
R01 · FY2019 · DA
Clean Indoor Air Laws, Cigarette Taxes, and Use of Smoking Cessation Treatments$368,438
R01 · FY2019 · DA · contact PI
Health Care Policy and Substance Abuse Treatment Access$380,078
R01 · FY2018 · DA
Clean Indoor Air Laws, Cigarette Taxes, and Use of Smoking Cessation Treatments$368,110
R01 · FY2018 · DA
The Impact of State Healthcare Reforms on Treatment of Substance Use Disorders$242,741
R01 · FY2018 · DA
Collaborative Child Mental Healthcare in Low-Resource Settings$210,337
R34 · FY2018 · MH · contact PI
Health Care Policy and Substance Abuse Treatment Access$394,504
R01 · FY2017 · DA
Clean Indoor Air Laws, Cigarette Taxes, and Use of Smoking Cessation Treatments$367,407
R01 · FY2017 · DA
The Impact of State Healthcare Reforms on Treatment of Substance Use Disorders$245,402
R01 · FY2017 · DA
The Impact of State Healthcare Reforms on Treatment of Substance Use Disorders$255,581
R01 · FY2016 · DA
Generalizing RCT Efficacy Evidence: Application to NIDA Clinical Trials Network$240,570
R01 · FY2016 · DA · contact PI
Generalizing RCT Efficacy Evidence: Application to NIDA Clinical Trials Network$239,355
R01 · FY2015 · DA · contact PI
Social Consequences of Mental Disorders: A Ten-Year Follow-up Study$279,623
R01 · FY2014 · MH · contact PI
Generalizing RCT Efficacy Evidence: Application to NIDA Clinical Trials Network$243,000
R01 · FY2014 · DA · contact PI
Social Consequences of Mental Disorders: A Ten-Year Follow-up Study$283,870
R01 · FY2013 · MH · contact PI
Treatment Patterns and Barriers in Comorbid Mental and Substance Disorders$238,620
R01 · FY2012 · DA · contact PI
Treatment Patterns and Barriers in Comorbid Mental and Substance Disorders$238,620
R01 · FY2011 · DA · contact PI
Treatment Patterns and Barriers in Comorbid Mental and Substance Disorders$246,000
R01 · FY2010 · DA · contact PI
CONTINUITY OF CARE &OUTCOME OF SEVERE MENTAL DISORDERS$171,579
K01 · FY2003 · MH
CONTINUITY OF CARE &OUTCOME OF SEVERE MENTAL DISORDERS$168,198
K01 · FY2002 · MH
CONTINUITY OF CARE &OUTCOME OF SEVERE MENTAL DISORDERS$163,977
K01 · FY2001 · MH
CONTINUITY OF CARE &OUTCOME OF SEVERE MENTAL DISORDERS$160,829
K01 · FY2000 · MH